Detailed information for compound 337472

Basic information

Technical information
  • TDR Targets ID: 337472
  • Name: 1-(7-hydroxynaphthalen-1-yl)-3-(3-methylsulfa nylphenyl)urea
  • MW: 324.397 | Formula: C18H16N2O2S
  • H donors: 3 H acceptors: 2 LogP: 3.89 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1cccc(c1)NC(=O)Nc1cccc2c1cc(O)cc2
  • InChi: 1S/C18H16N2O2S/c1-23-15-6-3-5-13(10-15)19-18(22)20-17-7-2-4-12-8-9-14(21)11-16(12)17/h2-11,21H,1H3,(H2,19,20,22)
  • InChiKey: GYHZBYPKMNZJKG-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-(7-hydroxy-1-naphthyl)-3-(3-methylsulfanylphenyl)urea
  • 1-(7-hydroxy-1-naphthyl)-3-[3-(methylthio)phenyl]urea

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Vanilloid receptor Starlite/ChEMBL References
Homo sapiens transient receptor potential cation channel, subfamily V, member 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis transient receptor potential cation channel 0.0008 1 1
Onchocerca volvulus Transient receptor potential cation channel trpm homolog 0.0008 0 0.5
Toxoplasma gondii 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein 0.0008 0 0.5
Onchocerca volvulus 0.0008 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0008 1 1
Toxoplasma gondii 3'5'-cyclic nucleotide phosphodiesterase domain-containing protein 0.0008 0 0.5
Toxoplasma gondii transporter, cation channel family protein 0.0008 0 0.5
Schistosoma mansoni transient receptor potential channel 0.0008 0.0001 0.0001
Schistosoma mansoni transient receptor potential channel 0.0008 0.9999 1
Echinococcus multilocularis short transient receptor potential channel 6 0.0008 0.9999 0.9999
Toxoplasma gondii transporter, cation channel family protein 0.0008 0 0.5
Toxoplasma gondii hypothetical protein 0.0008 0 0.5
Leishmania major hypothetical protein, unknown function 0.0008 0 0.5
Leishmania major calcium channel protein, putative,ion transporter, putative 0.0008 0 0.5
Leishmania major hypothetical protein, conserved 0.0008 0 0.5
Toxoplasma gondii transporter, cation channel family protein 0.0008 0 0.5
Trypanosoma cruzi inositol 1,4,5-trisphosphate receptor, putative 0.0008 0 0.5
Echinococcus granulosus transient receptor potential cation channel 0.0008 0.0001 0.0001
Trypanosoma brucei Voltage-dependent calcium channel subunit, putative 0.0008 0 0.5
Schistosoma mansoni transient receptor potential channel 0.0008 0.0001 0.0001
Trypanosoma brucei inositol 1,4,5-trisphosphate receptor 0.0008 0 0.5
Echinococcus multilocularis transient receptor potential cation channel 0.0008 1 1
Trypanosoma cruzi Voltage-dependent calcium channel subunit, putative 0.0008 0 0.5
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0008 0 0.5
Toxoplasma gondii hypothetical protein 0.0008 0 0.5
Echinococcus granulosus short transient receptor potential channel 6 0.0008 0.9999 0.9999
Loa Loa (eye worm) hypothetical protein 0.0008 0.0001 0.0001
Onchocerca volvulus Transient receptor potential cation channel trpm homolog 0.0008 0 0.5
Echinococcus multilocularis transient receptor potential cation channel 0.0008 0.0001 0.0001
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0008 0 0.5
Echinococcus granulosus transient receptor potential cation channel 0.0008 1 1
Echinococcus granulosus transient receptor potential cation channel 0.0008 0.0001 0.0001
Loa Loa (eye worm) hypothetical protein 0.0008 0.0001 0.0001

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 3.9 nM Antagonist activity at human TRPV1 expressed in CHO cells co-expressing aequorin and CRE-luciferase reporter gene assessed as inhibition of capsaicin-induced calcium flux ChEMBL. 21531136
IC50 (functional) = 7.1 nM Antagonist activity at rat TRPV1 expressed in CHO cells co-expressing aequorin and CRE-luciferase reporter gene assessed as inhibition of capsaicin-induced calcium flux ChEMBL. 21531136
IC50 (functional) = 13 nM Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced calcium mobilization ChEMBL. 18299195
IC50 (functional) = 13 nM Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced calcium mobilization ChEMBL. 18299195
IC50 (binding) = 22 nM Inhibition of binding to human vanilloid receptor subtype VR1 ChEMBL. 15689158
IC50 (binding) = 22 nM Inhibition of binding to human vanilloid receptor subtype VR1 ChEMBL. 15689158
IC50 (functional) = 35 nM Antagonist activity at rat TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced calcium mobilization ChEMBL. 18299195
IC50 (functional) = 35 nM Antagonist activity at rat TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced calcium mobilization ChEMBL. 18299195

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.